Diaceutics
As VP of Advisory Services Kevin identifies and supports the strategic growth of the business, leveraging key relationships internally and externally to drive success. Kevin leads and promotes the products and offerings supporting the further innovation of the business unit’s offerings to customers via customer led innovation, developing strategy for integrating services with DXRX. Kevin has over 13 years' experience working in the IVD and Pharma industry, with a focus on commercial strategy, commercialization of CDx in alignment with Rx launch and life cycle across global territories, working on regulatory approvals of IVDs including PMAs.
This person is not in any offices